Concepts (108)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Transcription, Genetic | 4 | 2015 | 134 | 0.470 |
Why?
|
| Papio | 3 | 2013 | 81 | 0.430 |
Why?
|
| Sarin | 3 | 2015 | 4 | 0.410 |
Why?
|
| Cholinesterase Inhibitors | 3 | 2015 | 37 | 0.400 |
Why?
|
| Kidney | 2 | 2018 | 523 | 0.360 |
Why?
|
| Papio hamadryas | 2 | 2018 | 15 | 0.340 |
Why?
|
| Gene Expression Regulation | 3 | 2015 | 475 | 0.280 |
Why?
|
| Fetal Development | 1 | 2018 | 27 | 0.280 |
Why?
|
| Hypertension | 2 | 2017 | 983 | 0.270 |
Why?
|
| Cardiovascular Diseases | 2 | 2017 | 1152 | 0.270 |
Why?
|
| Gene Expression Profiling | 4 | 2013 | 319 | 0.260 |
Why?
|
| Antiporters | 1 | 2017 | 9 | 0.260 |
Why?
|
| Sodium, Dietary | 1 | 2017 | 23 | 0.260 |
Why?
|
| Animals | 12 | 2021 | 7599 | 0.250 |
Why?
|
| Angiotensin II | 1 | 2017 | 245 | 0.230 |
Why?
|
| Renin-Angiotensin System | 1 | 2017 | 178 | 0.230 |
Why?
|
| Pregnancy, Animal | 1 | 2013 | 19 | 0.200 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2013 | 16 | 0.200 |
Why?
|
| Sequence Analysis, RNA | 1 | 2013 | 28 | 0.200 |
Why?
|
| Brain | 2 | 2015 | 949 | 0.200 |
Why?
|
| Fetal Growth Retardation | 1 | 2013 | 34 | 0.190 |
Why?
|
| Placenta | 1 | 2013 | 75 | 0.190 |
Why?
|
| Blood Pressure | 1 | 2017 | 867 | 0.190 |
Why?
|
| Fetal Heart | 1 | 2012 | 5 | 0.190 |
Why?
|
| Genome | 1 | 2012 | 38 | 0.180 |
Why?
|
| Epigenesis, Genetic | 1 | 2013 | 108 | 0.180 |
Why?
|
| RNA, Messenger | 4 | 2018 | 500 | 0.170 |
Why?
|
| Obesity | 2 | 2021 | 1179 | 0.140 |
Why?
|
| Pregnancy | 3 | 2013 | 981 | 0.120 |
Why?
|
| Primates | 2 | 2021 | 118 | 0.110 |
Why?
|
| Seizures | 2 | 2011 | 64 | 0.110 |
Why?
|
| RNA, Untranslated | 2 | 2013 | 10 | 0.100 |
Why?
|
| Rats | 4 | 2015 | 1610 | 0.090 |
Why?
|
| Septum of Brain | 1 | 2011 | 1 | 0.090 |
Why?
|
| Vesicular Transport Proteins | 1 | 2001 | 10 | 0.090 |
Why?
|
| Keratinocytes | 1 | 2001 | 29 | 0.090 |
Why?
|
| Thalamus | 1 | 2011 | 33 | 0.090 |
Why?
|
| Amygdala | 1 | 2011 | 59 | 0.080 |
Why?
|
| Epithelial Cells | 1 | 2001 | 129 | 0.080 |
Why?
|
| Cerebral Cortex | 1 | 2011 | 126 | 0.080 |
Why?
|
| Carrier Proteins | 1 | 2001 | 138 | 0.080 |
Why?
|
| Hippocampus | 1 | 2011 | 171 | 0.080 |
Why?
|
| Collagen | 1 | 2001 | 220 | 0.080 |
Why?
|
| Extracellular Matrix | 1 | 2001 | 243 | 0.080 |
Why?
|
| Male | 6 | 2017 | 19754 | 0.070 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2013 | 1068 | 0.070 |
Why?
|
| Wounds and Injuries | 1 | 2001 | 245 | 0.070 |
Why?
|
| Organ Specificity | 2 | 2013 | 80 | 0.070 |
Why?
|
| Female | 5 | 2021 | 20375 | 0.070 |
Why?
|
| Chagas Disease | 1 | 2017 | 7 | 0.070 |
Why?
|
| Sequence Alignment | 2 | 2012 | 61 | 0.070 |
Why?
|
| Humans | 7 | 2021 | 32968 | 0.070 |
Why?
|
| Caloric Restriction | 1 | 2017 | 103 | 0.060 |
Why?
|
| Signal Transduction | 2 | 2015 | 689 | 0.060 |
Why?
|
| Phenotype | 1 | 2017 | 644 | 0.060 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2013 | 12 | 0.050 |
Why?
|
| Caspase 3 | 1 | 2013 | 39 | 0.050 |
Why?
|
| INDEL Mutation | 1 | 2013 | 11 | 0.050 |
Why?
|
| Reference Standards | 1 | 2013 | 32 | 0.050 |
Why?
|
| Databases, Genetic | 1 | 2013 | 40 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2013 | 59 | 0.050 |
Why?
|
| Chromosome Mapping | 1 | 2013 | 193 | 0.050 |
Why?
|
| Pregnancy, Multiple | 1 | 2012 | 9 | 0.050 |
Why?
|
| Sheep, Domestic | 1 | 2012 | 18 | 0.050 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 497 | 0.050 |
Why?
|
| Cattle | 1 | 2012 | 108 | 0.050 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2012 | 69 | 0.040 |
Why?
|
| Diazepam | 2 | 2011 | 5 | 0.040 |
Why?
|
| Atropine | 2 | 2011 | 18 | 0.040 |
Why?
|
| Microarray Analysis | 2 | 2011 | 18 | 0.040 |
Why?
|
| Sex Factors | 1 | 2013 | 684 | 0.040 |
Why?
|
| Muscarinic Antagonists | 2 | 2011 | 14 | 0.040 |
Why?
|
| Bacteroides | 1 | 2021 | 8 | 0.040 |
Why?
|
| Prevotella | 1 | 2021 | 8 | 0.040 |
Why?
|
| Principal Component Analysis | 2 | 2011 | 68 | 0.040 |
Why?
|
| Gene Regulatory Networks | 2 | 2011 | 45 | 0.040 |
Why?
|
| Lactobacillus | 1 | 2021 | 13 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 770 | 0.040 |
Why?
|
| Feces | 1 | 2021 | 43 | 0.040 |
Why?
|
| Anticonvulsants | 2 | 2011 | 65 | 0.040 |
Why?
|
| Time Factors | 1 | 2015 | 2195 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2011 | 754 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2013 | 1015 | 0.040 |
Why?
|
| Diet | 1 | 2021 | 393 | 0.040 |
Why?
|
| Cholinesterase Reactivators | 1 | 2011 | 2 | 0.020 |
Why?
|
| Pralidoxime Compounds | 1 | 2011 | 2 | 0.020 |
Why?
|
| Oximes | 1 | 2011 | 6 | 0.020 |
Why?
|
| Xenopus | 1 | 2001 | 4 | 0.020 |
Why?
|
| Chemical Warfare Agents | 1 | 2011 | 14 | 0.020 |
Why?
|
| Interleukin-1beta | 1 | 2011 | 40 | 0.020 |
Why?
|
| Skin Physiological Phenomena | 1 | 2001 | 7 | 0.020 |
Why?
|
| Introns | 1 | 2001 | 39 | 0.020 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2001 | 10 | 0.020 |
Why?
|
| Neuropeptides | 1 | 2001 | 19 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2001 | 70 | 0.020 |
Why?
|
| Pyridines | 1 | 2011 | 75 | 0.020 |
Why?
|
| Phylogeny | 1 | 2001 | 62 | 0.020 |
Why?
|
| Exons | 1 | 2001 | 52 | 0.020 |
Why?
|
| Base Sequence | 1 | 2001 | 249 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2001 | 287 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2001 | 255 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2001 | 356 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2001 | 107 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2011 | 241 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2011 | 213 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2001 | 821 | 0.020 |
Why?
|
| Adult | 1 | 2021 | 9586 | 0.020 |
Why?
|
| Mice | 1 | 2001 | 2529 | 0.010 |
Why?
|